TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Recommended dose for expansion (RDE) of CUSP06
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Preliminary efficacy of CUSP06 as per RECIST
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: H2S measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants with eGFR < 60 ml/min/1.73 m2 or albuminuria
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Change in AES-C Score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Prognosis of facial motricity recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of mean RMSE value of ankle tracking performances
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of Brain MRI data acquisition
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Urine excretion (time curve (AUC))
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients with change HBsAg levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients with seroconversion to anti-HBs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline to Treatment for Non-Engagement
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change From Baseline to Treatment for Positive Items Sub-score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Quality of life at 3 months (EORTC QLQ C30)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Quality of life at 3 months (EORTC QLQ BN20)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Quality of life at 3 months (EQ-5D)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Area under the concentration curve (AUC0-t)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in drug consumption
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: urinary incontinence frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Lower urinary tract symptom score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Incidence of diabetes type 2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Trial Feasibility
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Safety and tolerability of COVAC-2 booster vaccine
Endpoint domain: Adverse events/effects
Primary endpoint: Maximum tolerated dose (MTD) of flotetuzumab
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximal incremental capillary blood glucose level (iCmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Maximum tolerated dose of APG-115
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum tolerated dose of APG-115+APG-2575
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the ROC Curve of POLQ expression
Endpoint domain: Mortality/survival
Primary endpoint: Rate of patients presenting loss of Shieldin complex and/or 53BP1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Oswestry Disability Score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Cmax of Rocbrutinib
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Margaret Blenkner Research Center (MBRC) Caregiver Strain instrument
Endpoint domain: Life impact
Endpoint subdomain: Societal/carer burden
Primary endpoint: Incidence of increase perirenal fat thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change of HAMD-17 total score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Trust perception
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Vaccination appointment booking
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: OMT frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Forced Expiratory Volume 1st second
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change from baseline in stimulated pituitary function (LH AUC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Response rates after Stage I
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: vascular outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: radiographic analysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total length of operative time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Brain Metabolism
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: moderate-to-vigorous physical activity (MVPA) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Internalizing Symptoms over time
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Physical Health Complaints over time on the PROMIS scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Resting Blood pressure (systolic and diastolic) mmHg
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Rate of Surviving or Died Participants with sepsis
Endpoint domain: Mortality/survival
Primary endpoint: Frequency of cesarean sections
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Changes from baseline in braking response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes from baseline in collisions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes from baseline in lane keeping
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes to the WOMAC A questionnaire
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Comparison of treatment-related Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Cough symptoms severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cPRA Concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: cf-DNA Concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Molecular gene expression profile
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of headache
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of muscle stiffness degree
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change of blood flow degree
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Change of posture
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Evolution of BMI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Workload capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of subjects with gallstones formed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of symptomatic gallstones
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Survival rate of gastric cancer
Endpoint domain: Mortality/survival
Primary endpoint: Outcome sting challenge vs. BAT Inhibition test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: target lesion failures (TLF) per 1 year
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DICE
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of acne patients who decide to join in a clinical study
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Rate of patients who remain in an acne clinical study to completion
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Total cardiovascular events
Endpoint domain: Mortality/survival
Primary endpoint: Total kidney events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Total death events
Endpoint domain: Mortality/survival
Primary endpoint: New onset or worsening frailty
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Single organ dysfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Multi-organ dysfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Problem Drinking Scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Posttraumatic Stress Symptom Severity Score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Neutrophil-to-Lymphocyte Ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change in fMRI brain activity pattern
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in behavior during fMRI task
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: physician's behavior change
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Progression-free survival (PFS) Rate at 12 months
Endpoint domain: Mortality/survival
Primary endpoint: Care Coordination Instrument Score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Taste and smell measures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Alcohol drinking behavior
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Palmar-plantar erythrodysesthesia (PPE) resolution
Endpoint domain: Adverse events/effects
Primary endpoint: Geometric Mean Ratio of ART Analytes Ctrough in plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants with ART Analyte Ctrough above threshold
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Trough serum total estradiol
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of solicited, unsolicited adverse and serious adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Vaccine-specific antibody concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Vaccine specific antibody neutralization capability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: McGill Test
Endpoint domain: Adverse events/effects
Primary endpoint: Quality of life survey sf-36
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Number of lung microplastics
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Incidence of Adverse Events or Dose Limiting Toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: Inflammatory profiling
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: numbers of all AEs
Endpoint domain: Adverse events/effects
Primary endpoint: change from baseline in systolic and diastolic blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: change from baseline in pulse rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Aesthetic improvement on the Wrinkle Severity Rating Scale (WSRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Performance characteristics of Ag-RDTs for SARS-CoV-2 detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Radioaerosol Pulmonary Deposition
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Self-efficacy for managing negative emotion
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Reduction in mean Intraocular Pressure (IOP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: MST memory performance
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Diaphragm and intercostal muscle function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Feasibility of lifestyle changes program
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Adherence (diet)
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: ICU mortality up to 1 day
Endpoint domain: Mortality/survival
Primary endpoint: LARC use 6 months postpartum
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change from Baseline Pre-ulcerative lesions and ulcers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Effect on the perception of fatigue
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Prevalence of attention deficit hyperactivity disorder
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Chronic Oral Mucosal Disease Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: gastrointestinal symptom
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Association with (pre)malignant disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Improvement on Fatigue Severity Score Scale (FSS)
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Sugaya score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: American Shoulder and Elbow Surgeons shoulder score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: University of California and Los Angeles shoulder score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Costant-Murley score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Range Of Motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants experiencing local and systemic reactions within 7 days of injection
Endpoint domain: Adverse events/effects
Primary endpoint: Number of physician-attended adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: newly discovered congenital anomaly
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Accurate diagnosis of inflammatory cardiomyopathy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Wijma Delivery Expectancy/Experience Questionnaire A (W-DEQ A)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Clinically important postoperative nausea and vomiting (CI-PONV)
Endpoint domain: Adverse events/effects
Primary endpoint: device stability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Anxiety Literacy
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in the endothelial derived extracellular vesicle population
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change in patient Prothrombin time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change in vital sign - BP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in vital sign - HR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Leg-length differences
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Knee Angle differences
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of mitral annular disjunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Measurement of ulcer size
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total Condomless Anal Sex Occurring in the Context of Insufficient PrEP Protection
Endpoint domain: Adverse events/effects
Primary endpoint: Successful Penile prosthesis implantation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Complete remission rate with negative minimal residual disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lowest oxygen saturation during tracheal intubation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Identification of the genetic cause
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of Adverse Events of Special Interest (AESI)
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Muscle Sympathetic Nerve Activity (MSNA) burst frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Muscle Sympathetic Nerve Activity (MSNA) burst incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: unplanned heart failure hospital admission
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: unplanned outpatient visit due to heart failure requiring intravenous diuretic therapy
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Graft-versus-host Disease (GvHD)
Endpoint domain: Adverse events/effects
Primary endpoint: Overall Response Rate (ORR) at 12 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physician Global Aesthetic Improvement Score (PGAIS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Relative change in liver-fat content
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Diagnostic sensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Change in variables related to intervention content
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Type and frequency of possible adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Number of intervention sessions attended out of planned
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Adverse events post SVF administration
Endpoint domain: Adverse events/effects
Primary endpoint: Upper limb functional status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hot Flash Score (HFS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Chlorhexidine gluconate bath documentation compliance
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Mean Standardized Weekly Kt/V
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: dTEL change
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Phase II clinical study recommended dose (RP2D)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Full Survey Completion
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Change in score on the PHQ-9
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in score on the GAD-7
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in score on the SF-36
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in score on the PHQ-15
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in score on the PSQI
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Change in score on the St George's Respiratory Questionnaire (SGRQ)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Composite vascular risk factor control
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Peak urinary [IGFBP7•TIMP-2]
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants Who Appropriately Will Self-select the Study Product
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Percentage of Participants Who Correctly Will Use the Study Product
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Total Drug Exposure (AUC(Inf))
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Static Physician Global Assessment
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Reduction of RBC transfusions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change in degree of pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perfusion index changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Numerical rating scale changes
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status